Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.62 |
| ▸ | PAM | P19021 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 7/20 | 0.52 |
| ▸ | CES1 | P23141 | 5/20 | 0.52 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL835850 | 1.00 | DGKA (0.62) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL2690121 | 1.00 | DGKA (0.62) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL2690448 | 1.00 | DGKA (0.62) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL21257687 | 1.00 | DGKA (0.62) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL21257703 | 1.00 | DGKA (0.62) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL2692664 | 0.98 | DGKA (0.59) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL2691702 | 0.92 | DGKA (0.50) | DGKAPAMTSHRMAPTFAAH | |
| SCHEMBL540976 | 0.90 | FAAH (0.59) | DGKAMAPTFAAHCES1KMT2A | |
| SCHEMBL540898 | 0.90 | FAAH (0.59) | DGKAMAPTFAAHCES1KMT2A | |
| SCHEMBL6297122 | 0.90 | HTT (0.48) | DGKAPAMTSHRMAPTFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1002123-A1 | ENZYMATIC KINETIC RESOLUTION OF AN INTERMEDIATE USEFUL FOR PREPARING SUBSTITUTED TRICYCLICS | SCHERING CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| US-6037166-A | MULTISTEP PROCESS USING HYDROLASE AND ACYLATING AGENT; OPTIONALLY CONVERTING UNDESIRED ISOMERS INTO RACEMATE BY HEATING AND RESUBJECTING TO PROCESS; FOR ANTIHISTAMINES AND INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | SCHERING CORPORATION (US) | 2000-03-14 | — | — | US | claimed |
| WO-1998058073-A1 | ENZYMATIC KINETIC RESOLUTION OF AN INTERMEDIATE USEFUL FOR PREPARING SUBSTITUTED TRICYCLICS | SCHERING CORPORATION (US) | 1998-12-23 | — | — | WO | claimed |
| WO-2005033076-A1 | METHOD FOR PREPARING 3-HYDROXY-4-HYDROXYMETHYL-PYRROLIDINE COMPOUNDS | INDUSTRIAL RESEARCH LIMITED (NZ) | 2005-04-14 | — | — | WO | disclosed |
| EP-0830136-B1 | NEW CRYPTOPHYCINS FROM SYNTHESIS | UNIV HAWAII (US) | 2004-10-20 | — | — | EP | disclosed |
| US-6180679-B1 | PARASITICIDE | ELI LILLY AND COMPANY | 2001-01-30 | — | — | US | disclosed |
| EP-0830136-A4 | NEW CRYPTOPHYCINS FROM SYNTHESIS | UNIV HAWAII (US) | 2001-01-24 | — | — | EP | disclosed |
| EP-1002123-A1 | ENZYMATIC KINETIC RESOLUTION OF AN INTERMEDIATE USEFUL FOR PREPARING SUBSTITUTED TRICYCLICS | SCHERING CORPORATION (US) | 2000-05-24 | — | — | EP | disclosed |
| US-6037166-A | MULTISTEP PROCESS USING HYDROLASE AND ACYLATING AGENT; OPTIONALLY CONVERTING UNDESIRED ISOMERS INTO RACEMATE BY HEATING AND RESUBJECTING TO PROCESS; FOR ANTIHISTAMINES AND INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | SCHERING CORPORATION (US) | 2000-03-14 | — | — | US | disclosed |
| US-6013626-A | TO INHIBIT THE PROLIFERATION OF MAMMALIAN CELLS; ANTITUMOR AGENTS | THE UNIVERSITY OF HAWAII (US) | 2000-01-11 | — | — | US | disclosed |
| WO-1998058073-A1 | ENZYMATIC KINETIC RESOLUTION OF AN INTERMEDIATE USEFUL FOR PREPARING SUBSTITUTED TRICYCLICS | SCHERING CORPORATION (US) | 1998-12-23 | — | — | WO | disclosed |
| EP-0870506-A1 | Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer | ELI LILLY AND COMPANY (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0870501-A1 | Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections | ELI LILLY AND COMPANY (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0870510-A2 | Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents | ELI LILLY AND COMPANY (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0830136-A1 | NEW CRYPTOPHYCINS FROM SYNTHESIS | UNIVERSITY OF HAWAII (US) | 1998-03-25 | — | — | EP | disclosed |
| WO-1996040184-A1 | NEW CRYPTOPHYCINS FROM SYNTHESIS | UNIVERSITY OF HAWAII (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5585252-A | CATALYTIC ACYLATION OF ALCOHOLS | G. D. SEARLE & CO. (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0560408-A1 | Enantio- and regioselective syntheses of organic compounds using enol esters as irreversible transacylation reagents | G.D. SEARLE & CO. (US) | 1993-09-15 | — | — | EP | disclosed |
| US-5106750-A | Enzymatic resolution of hydroxycyclopentenones using lipase | G. D. SEARLE & CO. (US) | 1992-04-21 | — | — | US | disclosed |
| EP-0357009-A2 | Method of resolution of hydroxy-cyclopentenones using a lipase and transacylation agents | G.D. Searle & Co. (US) | 1990-03-07 | — | — | EP | disclosed |